ALX Oncology Holdings(ALXO)
$1.01+0.00 (+0.50%)
ALXO
ALX Oncology Holdings ownership
$1.01
At close:+0.00 (+0.50%)
Want to see ALXO full AI Analyst Report?
ALX Oncology Holdings (ALXO) Ownership - Who Owns ALX Oncology Holdings?
462 Followers
ALX Oncology Holdings (ALXO) Ownership Overview
- 9.79% Insiders
- 6.81% Mutual Funds
- 53.77% Other Institutional Investors
- 6.76% ETFs
- 22.87% Public Companies and Individual Investors
The ownership structure of ALX Oncology Holdings (ALXO) stock is a mix of institutional, retail, and individual investors. Approximately 67.33% of the company’s stock is owned by Institutional Investors, 9.79% is owned by Insiders, and 22.87% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of ALX Oncology Holdings (ALXO) stock is a mix of institutional, retail, and individual investors. Approximately 67.33% of the company’s stock is owned by Institutional Investors, 9.79% is owned by Insiders, and 22.87% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 17, 2026 | Shelly Pinto | $1,106 | |
| Mar 22, 2026 | Jason Lettmann | $26,715 | |
| Mar 22, 2026 | Shelly Pinto | $1,960 | |
| Feb 19, 2026 | Shelly Pinto | $1,283 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | Entrypoint Capital, Llc | $27,262 | |
| Sep 30, 2026 | Graham Capital Management, L.p. | $192,992 | |
| Sep 30, 2026 | Blackstone Inc. | $9,418,005 | |
| Sep 30, 2026 | $10,720,767 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Corey Goodman | 13,052,008 | Insider | 9.44% | 13,117,268 |
| Peter Kolchinsky | 13,011,849 | Institution | 9.41% | 13,076,908 |
| BlackRock, Inc. | 7,712,782 | Institution | 5.58% | 7,751,346 |
| Stephen A. Schwarzman | 6,775,543 | Institution | 4.90% | 6,809,421 |
| Steve Weber | 6,025,240 | Institution | 4.36% | 6,055,366 |
| Vanguard Index Funds | 4,807,753 | Institution | 3.48% | 4,831,792 |
| Vanguard | 4,567,055 | Institution | 3.30% | 4,589,890 |
| Ishares | 3,830,455 | Institution | 2.77% | 3,849,607 |
| Fidelity Salem Street Trust | 1,274,983 | Institution | 0.92% | 1,281,358 |
| Fidelity Concord Street Trust | 832,608 | Institution | 0.60% | 836,771 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,807,753 | Institution | 3.48% | 4,831,792 |
| Fidelity Salem Street Trust | 1,274,983 | Institution | 0.92% | 1,281,358 |
| Fidelity Concord Street Trust | 832,608 | Institution | 0.60% | 836,771 |
| Vanguard Scottsdale Funds | 746,311 | Institution | 0.54% | 750,043 |
| Jpmorgan Trust I | 393,960 | Institution | 0.28% | 395,930 |
| Schwab Capital Trust | 260,212 | Institution | 0.19% | 261,513 |
| Tiaa-cref Funds | 236,398 | Institution | 0.17% | 237,580 |
| Bridgeway Funds, Inc. | 226,072 | Institution | 0.16% | 227,202 |
| Russell Investment Co | 146,676 | Institution | 0.11% | 147,409 |
| Goldman Sachs Trust | 83,966 | Institution | 0.06% | 84,386 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total Stock Market ETF, VTI ETF | 2,870,698 | Institution | 2.22% | 3,502,252 |
| iShares Russell 2000 ETF, IWM ETF | 2,602,038 | Institution | 2.01% | 2,615,048 |
| Vanguard Extended Market ETF, VXF ETF | 1,001,459 | Institution | 0.77% | 1,221,780 |
| iShares Russell 2000 Growth ETF, IWO ETF | 931,969 | Institution | 0.72% | 936,629 |
| Vanguard Russell 2000 ETF, VTWO ETF | 578,564 | Institution | 0.45% | 705,848 |
| iShares Micro-Cap ETF, IWC ETF | 296,229 | Institution | 0.23% | 297,710 |
| Goldman Sachs Activebeta U.S. Small Cap Equity ETF, GSSC ETF | 189,243 | Institution | 0.15% | 190,189 |
| EA Bridgeway Ultra-Small Company Market ETF, BUSM ETF | 164,365 | Institution | 0.13% | 164,365 |
| Fidelity Enhanced Small Cap ETF, FESM ETF | 130,808 | Institution | 0.10% | 130,808 |
| Vanguard Russell 2000 Growth ETF, VTWG ETF | 106,681 | Institution | 0.08% | 130,151 |
FAQ
Who Owns ALX Oncology Holdings (ALXO)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 67.33% of the company's stock is held by institutional investors, 9.79% is held by insiders, and 22.87% is held by public companies and individual investors.
What percentage of ALX Oncology Holdings (ALXO) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 67.33% of ALX Oncology Holdings (ALXO) stock is held by institutional investors: 6.81% by mutual funds, 6.76% by ETFs and 53.77% by other institutional investors.
What percentage of ALX Oncology Holdings (ALXO) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 22.87% of ALX Oncology Holdings (ALXO) stock is held by public companies and individual investors.
Who owns the most shares of ALX Oncology Holdings (ALXO)?
Corey Goodman owns the most shares of ALX Oncology Holdings (ALXO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

